A multicultural group practicing yoga together in a bright studio

Sprout Health vs Yucca Health: GLP-1 Comparison 2026

Sprout Health vs Yucca Health: pricing, medication type, clinical support, and which budget-conscious GLP-1 patient each program fits. Both programs’ prices verified August 2026 or later; each price carries its own date in the table below.

By RangeYourselfUpdated September 3, 20264 min read

Quick answer

Yucca Health typically wins on sticker price for compounded GLP-1. Choose Yucca Health if you're price-first; choose Sprout Health if you want brand-name (FDA-approved) access.

Side-by-side comparison

Feature	Sprout Health	Yucca Health
Best for	Balance of price and clinical support	Low advertised entry price on compounded GLP-1 with plain FDA disclosures and all-50-state provider coverage
Medication type	Compounded semaglutide and tirzepatide; brand-name Wegovy/Zepbound listed cash-pay	Compounded semaglutide and tirzepatide, once-weekly injection ('Semaglutide+' / 'Tirzepatide+'); also sells NAD+ and Sermorelin (out of registry scope)
Pricing model	Public 'starting at' monthly pricing on the homepage; higher doses/formats confirmed in the signup funnel	6-month prescription plans billed monthly/quarterly/6-month; advertised new-patient entry pricing; full pricing shared after intake
Semaglutide price	From $149/mo, advertised 'starting at' (compounded semaglutide, entry dose; homepage-verified 2026-08-21); personalized rate confirmed in the signup funnel	Compounded. Verbatim from tryyucca.com 2026-09-03: 'Semaglutide plans start at $125 per month with the 6-month plan ($750 total); the month-to-month plan is $146 per month.' The 6-month rate dropped $146 -> $125; $146 is now the published month-to-month rate. Page still notes 'Pricing is shared after intake once eligibility is confirmed.'
Tirzepatide price	From $199/mo, advertised 'starting at' (compounded tirzepatide, entry dose; homepage-verified 2026-08-21); personalized rate confirmed in the signup funnel	Compounded. Verbatim from tryyucca.com 2026-09-03: 'Tirzepatide plans start at $225 per month with the 6-month plan ($1,350 total); the month-to-month plan is $258 per month.' The 6-month rate dropped $258 -> $225; $258 is now the published month-to-month rate.
Key watchout	The $149 (semaglutide) / $199 (tirzepatide) figures are Sprout's advertised homepage 'starting at' entry-dose prices, verified on the homepage 2026-07-16. The signup funnel personalizes the final rate; higher doses and brand-name options (Wegovy ~$1,799/mo, Zepbound ~$1,999/mo) cost more, confirm your dose's rate at enrollment	The $125/mo figure is the 6-month-commitment semaglutide rate ($750 total); month-to-month is $146/mo. Dose-level pricing is still shared only after intake ('Pricing is shared after intake once eligibility is confirmed'), so confirm your dose's rate. Confirm your dose's ongoing rate at intake. Pharmacies are not named.
Price checked	Checked by a person August 21, 2026 · an automated check re-read it September 14, 2026	Checked by a person September 3, 2026 · an automated check re-read it September 14, 2026

When to choose Sprout Health

You want one of the lowest bundled compounded entry prices with clinician access
You're looking for compounded GLP-1 without a stripped-down service tier
You're comfortable confirming the recurring price in the signup funnel before committing
You may want to escalate dose with the same provider over time

Check current Sprout Health pricing →

When to choose Yucca Health

You want a low advertised entry price on compounded semaglutide or tirzepatide
You value an upfront 'not FDA-approved' compounding disclosure in the FAQ
You want provider coverage in all 50 states with free 2-day shipping
You're comfortable confirming your exact ongoing rate at intake (pricing beyond the entry offer is shared after eligibility)

Check current Yucca Health pricing →

Full reviews

Frequently asked questions

Is Sprout Health cheaper than Yucca Health?

Yucca Health starts lower on semaglutide (Compounded. Verbatim from tryyucca.com 2026-09-03: 'Semaglutide plans start at $125 per month with the 6-month plan ($750 total); the month-to-month plan is $146 per month.' The 6-month rate dropped $146 -> $125; $146 is now the published month-to-month rate. Page still notes 'Pricing is shared after intake once eligibility is confirmed.'). Sprout Health starts lower on tirzepatide (From $199/mo, advertised 'starting at' (compounded tirzepatide, entry dose; homepage-verified 2026-08-21); personalized rate confirmed in the signup funnel). Higher doses can shift the picture, so confirm pricing at the dose you're likely to use long-term.

Which is better for semaglutide or tirzepatide, Sprout Health or Yucca Health?

Yucca Health tends to win on semaglutide entry pricing; Sprout Health tends to win on tirzepatide entry pricing. Pick by which medication you'll be on long-term, not by the cheapest entry tier.

Are Sprout Health and Yucca Health compounded or brand-name?

Sprout Health offers compounded semaglutide and tirzepatide; brand-name wegovy/zepbound listed cash-pay. Yucca Health offers compounded semaglutide and tirzepatide, once-weekly injection ('semaglutide+' / 'tirzepatide+'); also sells nad+ and sermorelin (out of registry scope). If you specifically want brand-name Wegovy or Zepbound, lean toward whichever explicitly supports brand access; if compounded is fine, both can typically meet that need.

Can I switch from Sprout Health to Yucca Health?

Yes, switching between Sprout Health and Yucca Health is straightforward in most states. You typically finish your current month, complete a new intake with the other provider, and they handle the prescription. Watch for overlap on auto-renewal billing and confirm any dose-tier or formulation differences with the new clinician before your next shipment.

Compare Sprout Health and Yucca Health to other programs

Alert me when this gets cheaper

These prices move. Get one email when we publish a verified price drop, the programs on this list included. No spam. Unsubscribe any time.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers, verified on the dates shown in the table above, and may change. Numbers like $149/mo, advertised 'starting at' (compounded semaglutide, entry dose; homepage-verified 2026-08-21); personalized rate confirmed in the signup funnel and Compounded. Verbatim from tryyucca.com 2026-09-03: 'Semaglutide plans start at $125 per month with the 6-month plan ($750 total); the month-to-month plan is $146 per month.' The 6-month rate dropped $146 -> $125; $146 is now the published month-to-month rate. Page still notes 'Pricing is shared after intake once eligibility is confirmed.' are starting tiers, not your guaranteed long-term cost.